In a report released today, Amit Dayal from H.C. Wainwright reiterated a Buy rating on BioHarvest Sciences, with a price target of $14.00.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Amit Dayal has given his Buy rating due to a combination of factors including BioHarvest Sciences’ strong revenue growth and improved margins. The company’s 3Q25 results showed a significant increase in revenues, driven by the success of their core VINIA capsule business and the expanding ‘VINIA Inside’ product line. Additionally, the contribution from the CDMO segment has grown, supported by multiple customer engagements, which is a positive indicator of future revenue streams.
Furthermore, the company has strengthened its balance sheet, providing it with the financial flexibility to enhance marketing and sales efforts and potentially expand capacity to meet future demand. Despite a recent pullback in stock price, this presents an attractive entry point for investors, as the company continues to execute well on its growth strategies and improve its financial performance. These factors collectively support the Buy rating, reflecting confidence in the company’s ongoing growth and financial health.
According to TipRanks, Dayal is an analyst with an average return of -1.2% and a 34.56% success rate. Dayal covers the Industrials sector, focusing on stocks such as Plug Power, Vertical Aerospace, and Ceco Environmental.
In another report released on November 14, Maxim Group also reiterated a Buy rating on the stock with a $12.00 price target.